Experience of Idursulfase Beta Administration in the Child with Mucopolysaccharidosis Type II: Clinical Case

Background. Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a rare hereditary lysosomal storage disease associated with iduronate-2-sulfatase deficiency. Patients with MPS II require life-long enzyme replacement therapy (ERT) to replace the deficiency of endogenous enzyme. There are two m...

Full description

Bibliographic Details

Published in:	Вопросы современной педиатрии
Main Authors:	Tatiana K. Kruchina, Konstantin V. Bruchikov, Gennady A. Novik
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2020-12-01
Subjects:	mucopolysaccharidosis enzyme replacement therapy idursulfase beta children clinical case
Online Access:	https://vsp.spr-journal.ru/jour/article/view/2497